SQLite Web: event_store.db

Update row 478480 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-22T03:03:32.063787+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:80fdc92009b1f8ea","evidence_event_ids":["evt_680a3922ad8d"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt","as_of":"2026-04-22T03:03:32.063787+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt","company":"Twist Bioscience Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt","article_chars":2060,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_c3b1b1e872e9855a","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt","content_type":"text/plain","enriched_at":"2026-04-22T03:17:01.840930+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt","source_event_id":"evt_680a3922ad8d","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"c8a5c2c96e75e788","kind":"sec_filing","published_at":"20260421","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-21","2026-02-03","2026-02-23","2026-03-06","2026-03-20","2026-05-27","2026-04-21","2026-04-21","2025-05-27","2017-09-29"],"entities":[{"asset_class":"equity","name":"Twist Bioscience Corp","relevance":"high","symbol":"TWST","type":"issuer"},{"asset_class":"equity","name":"Emily M. Leproust","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Fidelity Brokerage Services LLC","relevance":"medium","symbol":"","type":"broker_or_intermediary"}],"event_type":"listing","information_gaps":["The provided text does not explicitly state the total number of shares to be sold across all lines beyond the individual transaction-date quantities shown.","The filing\u2019s per-transaction price/consideration is not clearly provided in the extracted text (only \u201cCash N\u201d and share counts are visible).","The signal is categorized as \u201clisting\u201d in the schema, but the content is specifically an SEC Form 144 disclosure; the schema category may not perfectly match the filing type.","What changed vs prior known state is not provided in the prompt (no prior filing state or comparison baseline included)."],"key_facts":["SEC accession number: 0001959173-26-003023.","Form type: 144 (conformed submission type: 144).","Filed as of date: 2026-04-21; date as of change: 2026-04-21.","Subject company/issuer: Twist Bioscience Corp (CIK: 0001581280; SEC file number: 001-38720).","Reporting owner: Emily M. Leproust (CIK: 0001753655).","Filing indicates the security is common stock (NASDAQ common).","The filing references: \u201cOption Granted - 09/29/2017\u201d and \u201cOption Granted - 09/29/2017 Issuer N\u201d.","The filing lists multiple transaction dates in 2026 with corresponding share quantities for Emily M. Leproust: 02/03/2026 (5001 shares), 02/23/2026 (7205 shares), 03/06/2026 (2423 shares), 03/20/2026 (1742 shares), and 04/21/2026 (1610 shares).","The filing also includes a \u201cCash N\u201d indicator and \u201cCommon\u201d security description repeated in the transaction lines.","Signature: /s/ Wade Moss, as attorney-in-fact for Emily M. Leproust (Fidelity Brokerage Services LLC)."],"numeric_claims":[{"label":"Total shares shown on 04/21/2026 line","value":"1610"},{"label":"Shares on 02/03/2026","value":"5001"},{"label":"Shares on 02/23/2026","value":"7205"},{"label":"Shares on 03/06/2026","value":"2423"},{"label":"Shares on 03/20/2026","value":"1742"},{"label":"Shares shown on 04/21/2026 (another line)","value":"1610"},{"label":"Option grant date referenced","value":"09/29/2017"},{"label":"Filing date (filed as of date)","value":"2026-04-21"}],"primary_claim":"On 2026-04-21, Twist Bioscience Corp filed SEC Form 144 (accession 0001959173-26-003023) for common stock transactions by Emily M. Leproust, including an option granted 09/29/2017 and multiple scheduled transaction dates in 2026.","relevance_score":0.55,"sentiment":"neutral","source_quality":"medium","summary":"Twist Bioscience Corp (TWST) filed a Form 144 on 2026-04-21 reporting sales/disposition of common stock by reporting owner Emily M. Leproust. The filing lists multiple transaction dates and share quantities, including an option granted on 09/29/2017.","topics":["SEC Form 144","insider/affiliate sale disclosure","common stock","Rule 144","Twist Bioscience Corp"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Twist Bioscience Corp \u00b7 Filed 20260421","ticker":"TWST","tickers":["TWST"],"title":"TWST filed 144","url":"https://www.sec.gov/Archives/edgar/data/1581280/0001959173-26-003023.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel